Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DC Vaccine + Preop Chemo in Breast Cancer
NCT02018458Phase 2Completed
- Sponsor
- Baylor Scott & White Research Institute
- Start
- May 2014
- Primary completion
- Sep 2019
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of cyclin b1 + wilms' tumor protein 1 + CEF + dendritic cell vaccine in breast cancer, sponsored by Baylor Scott & White Research Institute. Started May 2014; status: completed.
02
Drugs
cyclin b1 + wilms' tumor protein 1 + CEF + dendritic cell vaccine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02018458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02018458.